Skip to main content
logo
GSK plc (GLAXF)
OTCMKTS · Delayed Price · Currency is USD
23.99
+1.53 (6.81%)
Nov 21, 2025, 4:00 PM EST

Revenue

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
HIV Revenue
7.51B7.09B
Log In
Log In
Log In
Upgrade
Respiratory, Immunology and Inflammation Revenue
3.63B3.30B
Log In
Log In
Log In
Upgrade
Oncology Revenue
1.82B1.41B
Log In
Log In
Log In
Upgrade
Pandemic Revenue
--
Log In
Log In
Log In
Upgrade
Specialty Medicines Revenue
12.97B11.81B
Log In
Log In
Log In
Upgrade
Shingles Revenue
3.40B3.36B
Log In
Log In
Log In
Upgrade
Meningitis Revenue
1.57B1.44B
Log In
Log In
Log In
Upgrade
Influenza Revenue
328.00M408.00M
Log In
Log In
Log In
Upgrade
Established Vaccines Revenue
3.23B3.34B
Log In
Log In
Log In
Upgrade
Pandemic Vaccines Revenue
--
Log In
Log In
Log In
Upgrade
Vaccines Revenue
9.08B9.14B
Log In
Log In
Log In
Upgrade
Respiratory Revenue
7.09B7.21B
Log In
Log In
Log In
Upgrade
Other General Medicines Revenue
3.03B3.22B
Log In
Log In
Log In
Upgrade
General Medicines Revenue
10.12B10.43B
Log In
Log In
Log In
Upgrade
Total Commerical Operations Revenue
32.17B31.38B
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
US Revenue
16.74B16.38B
Log In
Log In
Log In
Upgrade
Europe Revenue
7.22B6.67B
Log In
Log In
Log In
Upgrade
International Revenue
8.20B8.33B
Log In
Log In
Log In
Upgrade

EBIT

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Commercial Operations Segment Profit
15.86B15.34B
Log In
Log In
Log In
Upgrade
Research & Development Segment Profit
-6.10B-5.85B
Log In
Log In
Log In
Upgrade
Updated Sep 30, 2025. Data Source: Fiscal.ai.